SKYE earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -0.44. Updated 2026-07-23.
Skye Bioscience (SKYE) Research Hub
Skye Bioscience (SKYE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.57 USD (+1.95%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.44, market cap 0.02B. This hub links to the full technical, earnings and options research available for SKYE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.57 USD (+1.95%) |
| 52-week range | 1.5 USD – 6.5 USD |
| Trend regime | Range |
| 14-day RSI | 45.6 (Neutral) |
| Trailing P/E | -0.44 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for SKYE
Covered Call on SKYE: how it works, illustrative setup around the real 1.57 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SKYE: how it works, illustrative setup around the real 1.57 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SKYE: how it works, illustrative setup around the real 1.57 USD price, max profit/loss, breakeven and when to use it. Educational.
SKYE technical analysis: range, last 1.57 USD, RSI 45.6, 52w range 1.5 USD–6.5 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SKYE in?
Skye Bioscience (SKYE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SKYE in an uptrend or downtrend?
As of 2026-10-26, SKYE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SKYE's trailing P/E ratio?
SKYE's trailing P/E is -0.44, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does SKYE next report earnings?
SKYE is next scheduled to report earnings on 2026-08-06.